-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Ovintiv, Raises Price Target to $80

Benzinga·11/04/2026 18:41:19
Listen to the news
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $75 to $80.